We are very pleased to present you today with a new version of the GliSODin scientific platform.
Now more than ever, strengthening our immune health is a priority – for those most at risk of a viral or a bacterial.
A French biotechnology company specialised for 15 years in protection from oxidative stress and its consequences on ageing. ISOCELL develops and manufactures clinically proven, high quality food supplements based on natural ingredients.
In 2001, François VIX founded ISOCELL and today, GliSODin dietary supplements are recognized worldwide
The Effect of Exogenous Superoxide Dismutase (SOD) on Caspase-3 Activation and Apoptosis Induction in Pc-3 Prostate Cancer Cells
Administration of superoxide dismutase (SOD) increased apoptosis in a prostate cancer cell line (PC-3) through the increased expression of caspase-3. Superoxide dismutase (SOD) can be onsidered as a therapy for late-stage prostate cancer that had been progressed to hormone resistant and metastasized and promote apoptosis in those prostate cancer cells
Protective role of a melon superoxide dismutase combined with gliadin (GliSODin) on the status of lipid peroxidation and antioxidant defense against azoxymethane-induced experimental colon carcinogenesis
The results of this study provide in vivo evidence that GliSODin reduced the AOM-induced colon cancer in rats, through their potent antioxidant activities.
Cucumis melo–gliadin inhibits endometriotic implants extension by decreasing MDA serum and TNF-α expression and resulted in lower VEGF expression compare with the control
This study aimed to assess the antioxidant activity of Melon GliSODin and its effectiveness in preventing NASH.
A randomized, open label, comparative, five-arm, controlled study evaluating the benefit and tolerability of oral superoxide dismutase combined with gliadin as add-on neutraceutical therapy with standard therapy in Indian patients with melasma
By inhibiting oxidative stress, nutraceutical SOD-Gliadin Combination offers significantly better efficacy and higher treatment satisfaction as add-on treatment compared to beta-carotene in Indian patients.
The results of our study suggest that oral SOD-gliadin may prevent or ameliorate RIF and patients can benefit from the positive effects of SOD.